Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation
Health Technology Assessment2013Vol. 17(55), pp. xv–xix, 1
Citations Over TimeTop 1% of 2013 papers
Norman Waugh, Eoin P. Cummins, P Royle, N-B Kandala, D Shyangdan, Ramesh Arasaradnam, Christine Clar, Rich D. Johnston
Abstract
The National Institute for Health Research Health Technology Assessment programme.
Related Papers
- → Calprotectin instability may lead to undertreatment in children with IBD(2019)35 cited
- → CO2 versus Air Insufflation for Private Practice Routine Colonoscopy: Results of a Randomized Double Blind Trial(2012)13 cited
- Pathogenesis and Treatment of Irritable Bowel Syndrome(2013)
- → Letter: faecal calprotectin for the prediction of relapse in inactive inflammatory bowel disease – authors’ reply(2016)
- Complementary treatments for irritable bowel syndrome(2012)